Actively Recruiting
Prospective Study of Rigicon Infla10 Inflatable Penile Prosthesis for Treating Erectile Dysfunction with Long-Term Safety and Effectiveness Follow-Up
Led by Rigicon, Inc. · Updated on 2026-08-13
182
Participants Needed
4
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate the long-term safety and effectiveness of the Rigicon Infla10 Inflatable Penile Prosthesis in men with erectile dysfunction ED. ED is a common male sexual health issue linked with aging and various health conditions, leading to difficulty achieving or maintaining an erection. The study focuses on patients implanted with this specific penile prosthesis and follows them for up to three years post-implantation to assess outcomes. Participants receive the Rigicon Infla10 three-piece inflatable penile prosthesis designed to help treat ED. The device is patient-activated to provide reliable spontaneity during intercourse. This study is a single-group, prospective trial assessing safety and efficacy through device-related adverse events and objective rigidity tests at 12 months, with ongoing assessments up to 36 months. Throughout the study, participants will attend scheduled follow-up visits to monitor device safety and effectiveness. Evaluations include physical exams, adverse event tracking, and questionnaires such as the International Index of Erectile Function and Rosenberg Self-Esteem Scale at multiple time points. The primary outcomes focus on safety events and penile rigidity at one year, with additional longer-term monitoring for device revisions and patient-reported outcomes over three years.
CONDITIONS
Brief Title
Evaluation of the Rigicon Infla10® Inflatable Penile Prosthesis (IPP) for Erectile Dysfunction
Research Team
Z
Zeynep Tin Konukcu
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here